Conor Hanley is CEO of FIRE1. Headquartered in Dublin, Ireland, FIRE1 is a connected medical device solutions company dedicated to improving outcomes for people suffering with chronic diseases. Its first product is a novel remote monitoring solution to improve outcomes for Heart Failure patients. FIRE1 originated from The Foundry in Menlo Park with investors including Medtronic, NEA, Lightstone Ventures, GILDE, GIMV and Seventure.

Conor Hanley previously worked with ResMed where he has held a number of senior management positions including leading up Chronic Disease management solutions globally, the global Cardiology business unit and the Ventures and Initiatives global business unit for corporate investments and accelerating new businesses.

Prior to ResMed, Conor was CEO and Co-Founder of BiancaMed, which was acquired by ResMed in 2011. BiancaMed grew as a spin out from University College Dublin and commercialized a novel, non-contact method to provide connected health solutions for wellness and medical applications. Over 7 years, he led a team that grew the company through three rounds of venture funding from top-tier international venture funds, launching products in Japan and USA (selling in major retailers, including the Apple store) and building the supply chain with mass production in China.

Conor was awarded a PhD in Chemical Engineering from the University of Pennsylvania, an MBA from INSEAD and a BEng from University College Dublin. Conor has completed the Leadership4Growth program at Stanford University and is a qualified Chartered Director from the Institute of Directors, UK.